Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02349633
Title Study For Patients With NSCLC EGFR Mutations (Del 19 or L858R +/- T790M)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Pfizer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
UC San Diego Medical Center - La Jolla La Jolla California 92037 United States Details
UC San Diego Moores Cancer Center La Jolla California 92093 United States Details
UC San Diego Medical Center - Hillcrest San Diego California 92103 United States Details
Smilow Cancer Hospital at Yale-New Haven New Haven Connecticut 06510 United States Details
UPMC Cancer Pavilion Pittsburgh Pennsylvania 15232 United States Details
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
Chris O'Brien Lifehouse Camperdown New South Wales 2050 Australia Details
Royal Prince Alfred Hospital Camperdown New South Wales 2050 Australia Details
Prince Charles Hospital, Cancer Care Services Chermside Queensland 4032 Australia Details
National Hospital Organization Shikoku Cancer Center Matsuyama Ehime 791-0280 Japan Details
The Cancer Institute Hospital of JFCR Koto-ku, Tokyo 135-8550 Japan Details
Seoul National University Hospital / Department of Internal Medicine Seoul 03080 Korea, Republic of Details
Severance Hospital, Yonsei University Health System Seoul 03722 Korea, Republic of Details
Asan Medical Center Seoul 05505 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field